BlueCheck for Enamel Lesions

ZB
Overseen ByZerita Buchanan, DDS, MPH
Age: Any Age
Sex: Any
Trial Phase: Phase 4
Sponsor: Colgate Palmolive
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The primary objective of this 12-week study is to test BlueCheck's ability to identify enamel lesions consistently, and its ability to track changes in these lesions over time.

Are You a Good Fit for This Trial?

This trial is for people who have enamel lesions or early cavities. Participants should be able to attend dental visits over a 12-week period and follow study instructions.

Inclusion Criteria

I am 13 years old or older.
Signed Informed Consent/Assent Form
Availability for the duration of the study
See 3 more

Exclusion Criteria

Subjects with fixed or removable orthodontic appliances or removable partial dentures
I have a weakened immune system or take medicines that lower my immunity.
Use of smokeless tobacco, vaping, or e-cigarettes or suspected substance abuse
See 11 more

What Are the Treatments Tested in This Trial?

Interventions

  • BlueCheck
  • Prevident 5000ppm Booster Plus Toothpaste

Trial Overview

The study is testing BlueCheck, a new tool for detecting and monitoring enamel lesions, alongside the use of Prevident 5000ppm Booster Plus Toothpaste. The goal is to see how well BlueCheck works over time.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Test GroupExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Colgate Palmolive

Lead Sponsor

Trials
106
Recruited
19,100+

Noel Wallace

Colgate Palmolive

Chief Executive Officer since 2019

MBA from Harvard Business School

Diana Haussling

Colgate Palmolive

Chief Marketing Officer since 2022

Bachelor's degree in Marketing

Dental Dreams, LLC

Collaborator